Comments
Loading...

Amneal Pharmaceuticals

AMRXNASDAQ
Logo brought to you by Benzinga Data
$8.80
0.11.09%
Last update: 10:40 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$4.00
Consensus Price Target1
$8.00

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock, Analyst Ratings, Price Targets, Forecasts

Amneal Pharmaceuticals Inc has a consensus price target of $8 based on the ratings of 7 analysts. The high is $10 issued by Barclays on August 13, 2024. The low is $4 issued by BMO Capital on March 3, 2023. The 3 most-recent analyst ratings were released by JP Morgan, Barclays, and Truist Securities on September 6, 2024, August 13, 2024, and August 12, 2024, respectively. With an average price target of $9.67 between JP Morgan, Barclays, and Truist Securities, there's an implied 9.79% upside for Amneal Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Mar
0
0
0
0
May
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Barclays
Truist Securities
Goldman Sachs
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Amneal Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Amneal Pharmaceuticals (AMRX) stock?

A

The latest price target for Amneal Pharmaceuticals (NASDAQ:AMRX) was reported by JP Morgan on September 6, 2024. The analyst firm set a price target for $9.00 expecting AMRX to rise to within 12 months (a possible 2.21% upside). 9 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Amneal Pharmaceuticals (AMRX)?

A

The latest analyst rating for Amneal Pharmaceuticals (NASDAQ:AMRX) was provided by JP Morgan, and Amneal Pharmaceuticals upgraded their neutral rating.

Q

When was the last upgrade for Amneal Pharmaceuticals (AMRX)?

A

The last upgrade for Amneal Pharmaceuticals Inc happened on September 6, 2024 when JP Morgan raised their price target to $9. JP Morgan previously had an underweight for Amneal Pharmaceuticals Inc.

Q

When was the last downgrade for Amneal Pharmaceuticals (AMRX)?

A

There is no last downgrade for Amneal Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Amneal Pharmaceuticals (AMRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amneal Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amneal Pharmaceuticals was filed on September 6, 2024 so you should expect the next rating to be made available sometime around September 6, 2025.

Q

Is the Analyst Rating Amneal Pharmaceuticals (AMRX) correct?

A

While ratings are subjective and will change, the latest Amneal Pharmaceuticals (AMRX) rating was a upgraded with a price target of $0.00 to $9.00. The current price Amneal Pharmaceuticals (AMRX) is trading at is $8.81, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch